Since stromal ST2 showed inverse correlation with stage and amount of desmoplasia, we evaluated other clinical factors involved in CRC prognosis, such as LN metastasis, tumor budding (TB) and macrophage markers (general marker CD68, M2-marker CD163, and M1-marker iNOS), analyzed by IHC. This evidence concerns the gene CD163 and colorectal carcinoma.